相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of methods for control allocation in multiple arm studies using response adaptive randomization
Kert Viele et al.
CLINICAL TRIALS (2020)
Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
Elizabeth G. Ryan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2020)
A Bayesian adaptive marker-stratified design for molecularly targeted agents with customized hierarchical modeling
Yong Zang et al.
STATISTICS IN MEDICINE (2019)
Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols
Jay J. H. Park et al.
TRIALS (2019)
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
Bob T. Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study
John D. Hainsworth et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Multiplicity Considerations in Clinical Trials
Alex Dmitrienko et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
G. W. Albers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
R. G. Nogueira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
Patrick Schoffski et al.
LANCET RESPIRATORY MEDICINE (2018)
Critical concepts in adaptive clinical trials
Jay J. H. Park et al.
CLINICAL EPIDEMIOLOGY (2018)
Master protocol trials in oncology: Review and new trial designs
Akihiro Hirakawa et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2018)
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
Brian M. Alexander et al.
CLINICAL CANCER RESEARCH (2018)
Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial
Keith W. Muir et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Programming With Models: Writing Statistical Algorithms for General Model Structures With NIMBLE
Perry de Valpine et al.
JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS (2017)
Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements
Edward L. Korn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements
Edward L. Korn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Critical Review of Umbrella, Basket, and Platform Designs for Oncology Clinical Trials
Richard Simon
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols
Mahesh K. B. Parmar et al.
CLINICAL TRIALS (2017)
The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model
Randall J. Bateman et al.
ALZHEIMERS & DEMENTIA (2017)
A Bayesian Credible Subgroups Approach to Identifying Patient Subgroups with Positive Treatment Effects
Patrick M. Schnell et al.
BIOMETRICS (2016)
Efficiencies of platform clinical trials: A vision of the future
Benjamin R. Saville et al.
CLINICAL TRIALS (2016)
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adaptive Randomization of Neratinib in Early Breast Cancer
J. W. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Aspiration Thrombectomy After Intravenous Alteplase Versus Intravenous Alteplase Alone
J. Mocco et al.
STROKE (2016)
Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials
P. Thall et al.
ANNALS OF ONCOLOGY (2015)
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
Roy S. Herbst et al.
CLINICAL CANCER RESEARCH (2015)
Are outcome-adaptive allocation trials ethical?
Spencer Phillips Hey et al.
CLINICAL TRIALS (2015)
The Platform Trial An Efficient Strategy for Evaluating Multiple Treatments
Scott M. Berry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The Brave New World of clinical cancer research: Adaptive biomarker-driven trials integrating clinical practice with clinical research
Donald A. Berry
MOLECULAR ONCOLOGY (2015)
Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
T. G. Jovin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
M. Goyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
B. C. V. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
O. A. Berkhemer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Not Too Big, Not Too Small: A Goldilocks Approach To Sample Size Selection
Kristine R. Broglio et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2014)
Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus
Jason T. Connor et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Adaptive Clinical Trials: The Promise and the Caution
Donald A. Berry
JOURNAL OF CLINICAL ONCOLOGY (2011)
Outcome-Adaptive Randomization: Is It Useful?
Edward L. Korn et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Optimal End Points for Acute Stroke Therapy Trials Best Ways to Measure Treatment Effects of Drugs and Devices
Jeffrey L. Saver
STROKE (2011)
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim et al.
CANCER DISCOVERY (2011)
Bayesian adaptive randomization designs for targeted agent development
J. Jack Lee et al.
CLINICAL TRIALS (2010)
I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
A. D. Barker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Optimal adaptive randomized designs for clinical trials
Yi Cheng et al.
BIOMETRIKA (2007)
Practical Bayesian adaptive randomisation in clinical trials
Peter F. Thall et al.
EUROPEAN JOURNAL OF CANCER (2007)
Bayesian clinical trials
DA Berry
NATURE REVIEWS DRUG DISCOVERY (2006)
Design and analysis of Phase III trials with ordered outcome scales: The concept of the sliding dichotomy
GD Murray et al.
JOURNAL OF NEUROTRAUMA (2005)
A group sequential, response-adaptive design for randomized clinical trials
TG Karrison et al.
CONTROLLED CLINICAL TRIALS (2003)
分享论文
